Latus Bio, Inc.
Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2
Funding history
1 round- $97M
Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2